Last reviewed · How we verify
Diarrhea Secondary to Inflammatory Bowel Disease
Approved treatments
- Imodium · Johnson & Johnson (McNeil Consumer Healthcare)
Peripheral mu-opioid receptor agonist that slows intestinal motility and increases fluid absorption without crossing the blood-brain barrier.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Diarrhea Secondary to Inflammatory Bowel Disease patent landscape — cliff calendar, originator estates, attackable patents
- Diarrhea Secondary to Inflammatory Bowel Disease treatment landscape brief
- Diarrhea Secondary to Inflammatory Bowel Disease treatment updates RSS
Frequently asked questions about Diarrhea Secondary to Inflammatory Bowel Disease
What drugs treat Diarrhea Secondary to Inflammatory Bowel Disease?
Tracked treatments include Imodium.
What is the treatment for Diarrhea Secondary to Inflammatory Bowel Disease?
Standard treatment for Diarrhea Secondary to Inflammatory Bowel Disease includes Imodium. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Diarrhea Secondary to Inflammatory Bowel Disease patent cliff · Diarrhea Secondary to Inflammatory Bowel Disease CI report
- Treatment: Imodium · Johnson & Johnson (McNeil Consumer Healthcare)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing